Biochemical markers of type 2 diabetes as a late complication of myocardial infarction: a case-control study.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28261283)

Published in Arch Med Sci on January 19, 2017

Authors

Olga Barbarash1, Olga Gruzdeva1, Evgenya Uchasova1, Ekaterina Belik1, Yulia Dyleva1, Victoria Karetnikova1

Author Affiliations

1: Federal State Budgetary Scientific Institution Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia.

Articles cited by this

Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med (2005) 28.21

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab (2000) 11.97

Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med (2006) 9.53

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J (2013) 5.23

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J (2008) 4.74

Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci U S A (2002) 4.40

The immune system and cardiac repair. Pharmacol Res (2008) 3.42

Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology (2003) 2.76

Fatty acid signaling in the beta-cell and insulin secretion. Diabetes (2006) 2.22

Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes. Diabetes (2002) 2.15

Tools for predicting the risk of type 2 diabetes in daily practice. Horm Metab Res (2008) 1.98

Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals. Circ Res (2007) 1.80

Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. J Hepatol (2007) 1.75

Regulation of the insulin gene by glucose and fatty acids. J Nutr (2006) 1.34

Role of adipokines in cardiovascular disease. J Endocrinol (2013) 1.34

The adrenergic-fatty acid load in heart failure. J Am Coll Cardiol (2009) 1.28

Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European Diabetes Prevention RCT in Newcastle upon Tyne, UK. BMC Public Health (2009) 1.16

Impact of physical activity on inflammation: effects on cardiovascular disease risk and other inflammatory conditions. Arch Med Sci (2012) 1.13

Glucose-insulin-potassium revived: current status in acute coronary syndromes and the energy-depleted heart. Circulation (2013) 0.98

Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents. Diabetes (2002) 0.98

Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Anesthesiology (2008) 0.95

Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease. Arch Med Sci (2013) 0.92

Elevated plasma retinol-binding protein 4 is associated with increased risk of type 2 diabetes in middle-aged and elderly Chinese adults. J Nutr (2014) 0.89

Significance of an index of insulin resistance on admission in non-diabetic patients with acute coronary syndromes. Heart (1999) 0.86

Relationship between free fatty acids, insulin resistance markers, and oxidized lipoproteins in myocardial infarction and acute left ventricular failure. Diabetes Metab Syndr Obes (2013) 0.83

[The role of markers of inflammation in assessment of prognosis in patients with ST-elevation myocardial infarction combined with disturbances of carbohydrate metabolism]. Kardiologiia (2012) 0.80

Articles by these authors

Impact of recipient-related factors on structural dysfunction of xenoaortic bioprosthetic heart valves. Patient Prefer Adherence (2015) 0.81